Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers. Volastra Therapeutics is backed by investors that include ARCH Venture Partners, Polaris Partners, Quark Venture, GF Securities, and DROIA and is headquartered in New York.